Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Flies are also attracted to hounds!!!!!
Flies are certainly attracted to what Ehrlich is and IPIX has become.
"This board has strangely become Lord of the Flies."
An excellent descriptor. Good choice!
Keep it classy, right?
This board has strangely become Lord of the Flies.
IPIX is dead. Insolvent. IPIX does not own Brilacidin. IPIX does not own Beamed. There’s nothing left. No company filings. No exchange of shares. No money. Fucked. These are the facts.
Are you fucked also since you were such a huge investor as per your past posts?????
If stating two facts on a msg board is pumping then what is the definition for what you are doing? Would it be trolling? You're fucked, I'm fucked, we're all fucked. Simple. The end result is all the same, the ground or sitting burnt in a jar. Well you ain't never caught a rabbit. so you ain't no friend of mine.
I have. The reason your IPIX account exists near a zero dollar basis is because your capital has been transferred to the company you’re pumping. A company that is no longer able to be traded on the open exchange. You’re fucked. It’s really that simple.
Do your own research. Poor bastards.
A link to the major patent issued for B would give your pie in the sky dream more credibility. Poor bastards.
Regardless of what anyone thinks here, a major patent was just issued for Brilacidin. The asset is strong. Besides the patent, there is due diligence going on. You can say whatever you want here but those two things are fact.
frenchbroad, you said, "They are one of many companies who sell Brilacidin." There is no question that IPIX is receiving a massive amount of attention with their amazing Brilacidin. It's good to hear that it has begun to translate into some revenue, and is sure to ramp up for the treatment of multiple indications going forward.
Interesting post by plotdog:
Biosynth is a over seas supplier of critical materials. Evidently those interested in Bril had a question as to whether it was manufactured in the presence of BSE or TSE. Biosynth replied no. This could be interested partner inquires. Fingers crossed
I wouldn't know how to go about it.
There's nothing stopping a distributor from putting a product in a catalog without actually stocking it.
Any shipments of brilacidin to a distributor for resale would have to have been treated as revenue in the financials.
Is it provable that *anyone* is actually selling or buying bril?
Can you explain why IPIX has never recorded a single dollar of revenue from the sale of brilacidin that you say that you own?
Also interesting is Biosynth asks USD$4339 to buy 25mg of Brilacidin.
They are one of many companys who sell Brilacidin.
https://www.biosynth.com/advanced/search-results?searchtype=1&query=BRILACIDIN%20TETRAHYDROCHLORIDE
This is also from the same company (Biosynth)website: Interesting…,
ZYB09599
Brilacidin tetrahydrochloride
Brilacidin tetrahydrochloride is an analog of a naturally occurring peptide that has been shown to have anticancer properties. It works by inhibiting the activity of kinases, which are enzymes that play a critical role in cancer cell growth and survival. Brilacidin tetrahydrochloride has been shown to induce apoptosis, or programmed cell death, in tumor cells. In addition to its anticancer effects, this compound also has potential as an inhibitor of protein kinase C (PKC), which is involved in a variety of signaling pathways. Brilacidin tetrahydrochloride has been studied in Chinese hamster ovary cells and human urine samples, and it shows promising results as a potential anticancer agent. It may also have potential therapeutic applications for other diseases such as dabigatran-induced nephropathy.
A BSE/TSE statement is requested by countries to prevent imports that could potentially contain ingredients associated with Bovine Spongiform Encephalopathy (BSE) or other transmissible spongiform encephalopathies (TSEs)12. BSE is a degenerative neurological disease affecting cattle2.
It's an assurance that the product that Biosynth is distributing is not being manufactured in the presence of mad cow or related disease.
I think they are refering to it in regards to Brilacidin beeing a AMP/HDP.
Interesting letter regarding Bril posted by fit over at ST-- https://www.biosynth.com/Files/Gen/Tse/ZYB09599
Per Biosynth website- Brilacidin tetrahydrochloride is an analog of a naturally occurring peptide that has been shown to have anticancer properties.
I personally can't get amped on a big up day under 5 cents as I don't get depressed at down days since IMO it is just game playing. Now if it was for 200MM shares that might be another matter.
What I looked at was only for me to edit, I guess. PM hangout.
Luv to see RoaringKitty burn shorts.
+ 150%, someone please wake the rally monkey!
"Regeneron worked for 18 years to find a first partner."
How many years was it before their CEO ran away and hid from investors, failing to provide any public information?
(Actually he's still there....been there since 1988.)
No more Regeneron stories, please. The one single point of comparison is a lack of success in the early years. Nothing else.
We get it. You don’t like being reminded about your failures and we know it wasn’t ignorance that got you there.
Pete, congrats on your books. I could not find your email address in your profile.
Congratulations Pete and hope you sell a million!
Once again, my point is proven.
Thank you Pennywise.
The reason to sell now would be to reap the capital loss; the pittance received would be negligible. The potential reward could be immense.
The level of remorse and embarrassment for selling at the bottom is unacceptable. That this was other than speculation from the beginning is fantasy.
Even at the current price, I would be a buyer if I were an 'expert'.
gh
IPIX is dead, but it’s still the life of the party for those not holding the bag! Poor bastards.
And yet you continue to beat a dead horse. Sad.
What is the point of arguing about this? What will be will be. No one is selling shares at this point and very few can buy.
Take a look around. The CEO is gone. Your shares are worthless. The company is dead.
The naked short conspiracy was debunked years ago when Leo changed the co name from ctix to ipix.
No real trading (all will be naked shorts) under 5cents IMO.
Since very little news being posted, FYI for all I just had 2 books get put on Amazon; one a golf novel and one a veteran-based novel. If interested in their titles, email me as I have posted my address on my profile and I will send anyone wanting it a private email.
You have spent a copious amount of time here, years now, commenting on a "dead" company.
Who's the clown?
Carry on.
Frenchfraud, given your pathetic "research" skills that resulted in such an erroneous calculation/conclusion, I can see why you are heavily invested in this garbage and why you make such outrageous statements on this board. Hopefully, you haven't led too many sheep over the edge of the cliff. What will your excuses be when you finally realize it's game over? Track down those missing press releases yet?
I think Ehrlich has mentally shuttered IPIX, and is waiting expectantly for the inevitable SEC suspension and subsequent delisting.
As IPIX is a limited company he will have no personal liability for the approximately $1.5 million owed to Cummings, and he will use the resulting bankruptcy to explain why shareholders receive nothing once the company is wound up (shareholders are always bottom of the list, behind even the employees whose improvident actions (that's being polite) caused the bankruptcy).
He will hope avidly and probably successfully that no one ever really follows the money, particularly his shark-jumping gift of $4 million to an off-shore private company and the issue of millions of cheap shares to his Aspire and Kips' Bay buddies.
It's penny stock grifting 101, and IPIX isn't Leo's first rodeo.
Spots, what do you think is happening here, if anything?
Were the Directors foolish to resign? Will CEO Leo Ehrlich ever be heard from again?
Will these be the last words the public ever hears from this Company?
You don’t own Brilacidin. You don’t own Beamed. Neither does IPIX. You’re a fool.
IPIX is dead. You’re pumping a ticker that isn’t even tradable. Clown.
16000 posts who say all the same: Ipix is bad.
We can say 2 minutes to read a post. An other 2 minutes to write reply and find a new silly name for Mr. Ehrlich.
It is 64000 minutes. 1066 hours of work. Maybe much more.
All for a thing you say is nothing.
Days and weeks and months. You have Lost Them All.
"When positive news breaks, buying will be a free-for-all". LOL. Doubt there will be any positive news but how do you propose there to be a buying frenzy? Will the wasteland known as the "Expert" market suddenly open its gates for a day to accommodate this imaginary press release and allow this buying free for all? You are living in the land of make believe and lost investments. False hopes/ignore reality.
Maybe the recluse, Lost It All Leo, can do a Google Search press release. This debacle is an absolute disaster. If Brilacidin was as great as you believe it to be, this pile of junk would not be on life support. And given Error Prone Ehrlich's track record, I seriously doubt BeaMed will pull Ehrlich out of the sewer. If BeaMed is a great as you believe it to be, why would the Laser Boys sell such a large percentage to the idiot for $4 million - a lot for cash-strapped Ehrlich in a move that left his company with no funds but a pittance if the Laser Boys believed their product was a blockbuster. Doubt the Laser Boy would be so stupid. "A fool and his money......" Your IPIX portfolio must look like a nuclear bomb went off.
Followers
|
973
|
Posters
|
|
Posts (Today)
|
1
|
Posts (Total)
|
403624
|
Created
|
05/10/08
|
Type
|
Free
|
Moderators zandant sunspotter snayeman loanranger frenchbroad |
Innovation Pharmaceuticals Inc. (IPIX)
$IPIX NEWS - http://ipharminc.com/press-release
SEC Filings https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany
From the most recent 10-K:
There are doubts about our ability to continue as a going concern.
We have generated revenue of $0 and $18,000 for the fiscal years ended June 30, 2023 and 2022, respectively and have an accumulated deficit of $125.3 million through June 30, 2023. These factors raise substantial doubt about our ability to continue as a going concern.
We need to raise substantial additional capital in the future to fund our operations and we may be unable to raise such funds when needed and on acceptable terms, which could prevent us from fully implementing our business, operating and development plans.
We currently have an approximate $1.0 million cash balance as of the date of this filing, but that is insufficient to complete the development and commercialization of any of our proposed products. We expect to incur costs of approximately $1.8 million in the upcoming fiscal year ending June 30, 2024 to operate our business in accordance with our business plans and budgets.
We have limited experience in drug and formulation development, the conduct of clinical trials, and may not be able to successfully develop any drugs.
Development of pharmaceutical products is a risky and time-consuming process subject to a number of factors, many of which are outside of our control. We are subject to regulatory authority permissions and approvals, most importantly the FDA. Our drug candidate(s)/indications are at early and mid-stages of development. Consequently, we can provide no assurance of the successful and timely development of new drugs, and the failure to do so could cause us to cease operations.
We may elect to deregister our common stock under the Exchange Act and suspend our reporting obligations. Such deregistration and suspension would result in less disclosure about us and may negatively affect the liquidity and trading prices of our common stock.
http://www.ipharminc.com/
About Innovation Pharmaceuticals Inc.:
Established in 2007, and headquartered in Wakefield, Massachusetts, Innovation Pharmaceuticals Inc. (formerly Cellceutix Corporation) is a publicly traded biopharmaceutical company dedicated to discovering and advancing innovative medical therapies with dermatology, oncology, anti-inflammatory and antibiotic applications.
Through ongoing research and drug development efforts, Innovation is focused on improving the clinical care of patients, as well as growing shareholder value. Our team consists of a diverse and accomplished group of professionals working together toward achieving this common goal.
IPIX CEO - "The Company historically devoted most of its efforts and resources on business development, regulatory matters, and clinical trials. Presently, the Company does not have sufficient financial resources to advance our drug candidates meaningfully." "In general, we expect to concentrate on product development and engage in a limited way in product discovery, avoiding the significant investment of time and financial resources that is generally required for a promising compound to be identified and brought into clinical trials." Source - https://www.sec.gov/ix?doc=/Archives/edgar/data/1355250/000147793223003414/ipix_10q.htm
More information is available at http://www.ipharminc.com.
Management: http://www.ipharminc.com/senior-management/
Scientific Advisors: http://www.ipharminc.com/scientific-advisors/
Clinical Trials: https://clinicaltrials.gov/ct2/results?cond=&term=%22Innovation+Pharmaceuticals%2C+Inc.%22++&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps
Trials under previous name: https://clinicaltrials.gov/ct2/results?cond=&term=cellceutix&cntry=&state=&city=&dist=&Search=Search&flds=abcefgps
Product Pipeline: http://www.ipharminc.com/therapeutic-areas/
Recent News and Press Releases:
https://finance.yahoo.com/quote/IPIX?p=IPIX
http://www.ipharminc.com/press-release/
SEC Filings (CIK:0001355250): https://www.sec.gov/cgi-bin/browse-edgar?company=Innovation+Pharmaceutical&owner=exclude&action=getcompany
Transfer Agent:
West Coast Stock Transfer, Inc.
721 N. Vulcan Ave. Ste. 205
Encinitas, CA 92024
(619) 664-4780 p
(760) 452-4423 f
cs@wcsti.com
http://www.westcoaststocktransfer.com
Share Structure: See SEC filing link above for current share structure
Investor Relations:
http://www.ipharminc.com/new-faq/
http://www.ipharminc.com/contact-us-1
Chart: https://stockcharts.com/h-sc/ui?s=IPIX
All messages, including iBox content, are the opinion of the posters, are no substitute for your own research, and should not be relied upon for stock trading or any other purpose.
Also, keep in mind that moderators may or may not have a position in said stock. Being a moderator isn’t a sign of endorsement.
Please keep your posts on topic because your message(s) will probably be deleted when:
* Posting content that's off-topic to the subject of this board;
* Posting statements that don't add value to the discussion; or
* When you violate any other posting term of the iHub User Agreement: http://investorshub.advfn.com/boards/complex_terms.asp
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |